JUVENOCT Trademark

Trademark Overview

On Friday, August 9, 2013, a trademark application was filed for JUVENOCT with the United States Patent and Trademark Office. The USPTO has given the JUVENOCT trademark a serial number of 79139166. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, August 8, 2023. This trademark is owned by Octapharma AG. The JUVENOCT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely blood coagulation factors, particularly recombinant factors VIII
juvenoct

General Information

Serial Number79139166
Word MarkJUVENOCT
Filing DateFriday, August 9, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, August 8, 2023
Registration Number4500109
Registration DateTuesday, March 25, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2014

Trademark Statements

Goods and ServicesPharmaceutical products, namely blood coagulation factors, particularly recombinant factors VIII

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOctapharma AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameOctapharma AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameOctapharma AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Sunday, March 3, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, March 3, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, April 17, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, March 10, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, March 10, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Thursday, August 18, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 11, 2016NEW REPRESENTATIVE AT IB RECEIVED
Thursday, August 11, 2016NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 4, 2014NOTIFICATION PROCESSED BY IB
Monday, June 16, 2014FINAL DISPOSITION NOTICE SENT TO IB
Monday, June 16, 2014FINAL DISPOSITION PROCESSED
Thursday, April 24, 2014GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, March 25, 2014REGISTERED-PRINCIPAL REGISTER
Friday, March 7, 2014NOTIFICATION PROCESSED BY IB
Tuesday, January 7, 2014PUBLISHED FOR OPPOSITION
Friday, January 3, 2014NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, December 18, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 18, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 18, 2013NOTICE OF PUBLICATION
Saturday, December 7, 2013APPLICATION FILING RECEIPT MAILED
Thursday, December 5, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 3, 2013ASSIGNED TO EXAMINER
Tuesday, December 3, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 28, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

juvenoct factors particularly viii recombinant coagulation products namely blood pharmaceutical